Sarcomatoid/biphasic and epithelioid mesotheliomas showed different MDM2 and HIF1alpha expression levels and were characterized by different levels of necrosis, proliferation and inflammation. The gene discussed is MDM2; the disease is malignant epithelioid mesothelioma.